Highlights Consun Pharmaceutical Group Limited

Equities

1681

KYG2524A1031

Market Closed - Hong Kong S.E. Other stock markets 04:08:20 2024-05-14 EDT			5-day change	1st Jan Change
7.16 ^HKD	+9.65%		+18.94%	+50.10%

05-07	Consun Pharmaceutical to Grant About 8.2 Million Share Options Under New Program	MT
03-29	Consun Pharmaceutical Group Sees 15% Increase in 2023 Profit	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Consun Pharmaceutical to Grant About 8.2 Million Share Options Under New Program	05-06	MT
Consun Pharmaceutical Group Sees 15% Increase in 2023 Profit	03-29	MT
Consun Pharmaceutical Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 21 June 2024	03-28	CI
Consun Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	03-28	CI
Consun Pharmaceutical's H1 Profit Rises on Higher Revenue	23-08-24	MT
Consun Pharmaceutical Group Limited Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on 20 September 2023	23-08-24	CI
Consun Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
Consun Pharmaceutical Group Limited Approves Final Dividend for the Year Ended 31 December 2022	23-05-31	CI
Consun Pharmaceutical Group Limited Declares Final Dividend for the Year Ended December 31, 2022	23-04-27	CI
Chinese Regulator Approves Consun Pharmaceutical's Clinical Trial for Kidney Disease Treatment	23-04-17	MT
Consun Pharmaceutical Group Limited Receives Approval for Clinical Trial of Drug for SK-07 Injection	23-04-16	CI
Consun Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-23	CI
Consun Pharmaceutical Group Limited Proposes to Pay A Final Dividend for the Year Ended December 31, 2022, Payable on or About June 21, 2023	23-03-23	CI
Consun Pharmaceutical Group Sees Surge in 2022 First-Half Profit	22-09-23	MT
Consun Pharmaceutical's H1 Profit Rises on Higher Revenue	22-08-26	MT
Consun Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-26	CI
Wanbangde Pharma in Talks to Buy Controlling Stake in Consun Pharma	22-07-26	MT
Consun Pharmaceutical Group Limited, A Wholly-Owned Subsidiary of Consun Pharmaceutical Co., Ltd Holds A Trial Production Ceremony in Plant No. 8, Area A05, Horgos Comprehensive Bonded Zone, Yili Kazakh	22-06-20	CI
Consun Pharmaceutical Group Limited Approves Final Dividend for the Year Ended December 31, 2021	22-05-27	CI
Consun Pharmaceutical Group Limited Proposes Final Dividend for the Year Ended 31 December 2021, Payable on or About 17 June 2022	22-04-25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Consun Pharmaceutical Group Limited

Equities

1681

KYG2524A1031

Highlights

Filters